Indoco Remedies Limited has informed the Exchange about Product launch. Please find enclosed Press Release in this regards.
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indoco Remedies, via its UK subsidiary Indoco Remedies UK Limited, has launched Ticagrelor film-coated tablets 90mg in the United Kingdom on June 2, 2025. Ticagrelor is an antiplatelet medication used to reduce the risk of heart attack, stroke, and other cardiovascular events. The product will be marketed and distributed across the UK by Clarity Pharma. This adds to Indoco's international portfolio, and the company has a turnover of about US$180 million with 11 manufacturing facilities approved by regulators including USFDA and UK-MHRA.
Positive for shareholders as it expands Indoco's footprint in the regulated UK market and strengthens its cardiovascular therapeutic segment, though the financial impact on revenue is not disclosed in this announcement.